These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2869140

  • 1. Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices.
    Wolf ME, Galloway MP, Roth RH.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):699-707. PubMed ID: 2869140
    [Abstract] [Full Text] [Related]

  • 2. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
    Galloway MP, Wolf ME, Roth RH.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
    [Abstract] [Full Text] [Related]

  • 3. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
    Hoffmann IS, Talmaciu RK, Ferro CP, Cubeddu LX.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
    [Abstract] [Full Text] [Related]

  • 4. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
    Clark D, Salah RS, Galloway MP.
    Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
    [Abstract] [Full Text] [Related]

  • 5. Regulation of dopamine and serotonin synthesis by acute administration of cocaine.
    Galloway MP.
    Synapse; 1990 Jul; 6(1):63-72. PubMed ID: 2119072
    [Abstract] [Full Text] [Related]

  • 6. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
    Bongiovanni R, Young D, Newbould E, Jaskiw GE.
    Brain Res; 2006 Oct 18; 1115(1):26-36. PubMed ID: 16934236
    [Abstract] [Full Text] [Related]

  • 7. Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum.
    Bohmaker K, Puza T, Goldstein M, Meller E.
    J Pharmacol Exp Ther; 1989 Jan 18; 248(1):97-103. PubMed ID: 2563295
    [Abstract] [Full Text] [Related]

  • 8. Dopamine neurons projecting to the medial prefrontal cortex possess release-modulating autoreceptors.
    Wolf ME, Roth RH.
    Neuropharmacology; 1987 Aug 18; 26(8):1053-9. PubMed ID: 3658117
    [Abstract] [Full Text] [Related]

  • 9. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
    Faggin BM, Zubieta JK, Rezvani AH, Cubeddu LX.
    J Pharmacol Exp Ther; 1990 Feb 18; 252(2):817-25. PubMed ID: 2138224
    [Abstract] [Full Text] [Related]

  • 10. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
    Meller E, Bohmaker K, Namba Y, Friedhoff AJ, Goldstein M.
    Mol Pharmacol; 1987 Jun 18; 31(6):592-8. PubMed ID: 2885734
    [Abstract] [Full Text] [Related]

  • 11. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
    Jackson D, Abercrombie ED, Zigmond MJ.
    J Pharmacol Exp Ther; 1993 Nov 18; 267(2):912-8. PubMed ID: 8246167
    [Abstract] [Full Text] [Related]

  • 12. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
    Rugsley TA, Davis MD, Akunne HC, Cooke LW, Whetzel SZ, MacKenzie RG, Shih YH, van Leeuwen DH, DeMattos SB, Georgic LM.
    J Pharmacol Exp Ther; 1995 Aug 18; 274(2):898-911. PubMed ID: 7636753
    [Abstract] [Full Text] [Related]

  • 13. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.
    Dwoskin LP, Zahniser NR.
    J Pharmacol Exp Ther; 1986 Nov 18; 239(2):442-53. PubMed ID: 3772803
    [Abstract] [Full Text] [Related]

  • 14. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H, Lovenberg T, Cubeddu LX.
    J Pharmacol Exp Ther; 1987 Dec 18; 243(3):840-51. PubMed ID: 3320346
    [Abstract] [Full Text] [Related]

  • 15. Modulation of dopamine release by striatal 5-HT2C receptors.
    Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA.
    Synapse; 2005 Mar 15; 55(4):242-51. PubMed ID: 15668911
    [Abstract] [Full Text] [Related]

  • 16. Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.
    Johnson EA, Tsai CE, Shahan YH, Azzaro AJ.
    J Pharmacol Exp Ther; 1993 Jul 15; 266(1):133-41. PubMed ID: 8101215
    [Abstract] [Full Text] [Related]

  • 17. Depolarisation-evoked release of dopamine and histamine from brain tissue and studies on presynaptic dopamine-histamine interaction.
    Nowak JZ.
    Pol J Pharmacol Pharm; 1985 Jul 15; 37(3):359-81. PubMed ID: 2866503
    [Abstract] [Full Text] [Related]

  • 18. Regulation of dopaminergic activity, but not tyrosine hydroxylase, is diminished after chronic inorganic lead exposure.
    Lasley SM.
    Neurotoxicology; 1992 Jul 15; 13(3):625-35. PubMed ID: 1361980
    [Abstract] [Full Text] [Related]

  • 19. Biphasic modulation of evoked [3H]D-aspartate release by D-2 dopamine receptors in rat striatal slices.
    Peris J, Dwoskin LP, Zahniser NR.
    Synapse; 1988 Jul 15; 2(4):450-6. PubMed ID: 2973144
    [Abstract] [Full Text] [Related]

  • 20. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
    Matthews RT, McMillen BA, Sallis R, Blair D.
    J Pharmacol Exp Ther; 1986 Oct 15; 239(1):124-31. PubMed ID: 2876091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.